Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Merck
Harvard Business School
Express Scripts
Boehringer Ingelheim

Friction-free sign-up with instant access

Accurate, objective, and timely intelligence to help you make better decisions


4.3/5 based on G2 reviews

4.4/5 based on Crozdesk reviews

Flexible Pricing Adapts to Your Needs


 

Free

Limited free access

$0

 
  • Limited searches each month
  • Some restrictions on platform functions
 

Limited

For low-volume use

Starting at $250

/ month
  • Includes all Modules
  • Copy of Make Better Decisions book
  • Weekly Briefing Email Bulletin
  • 35 searches per month
  • Limited Support
MOST POPULAR 

Unlimited

Simple flat-rate access

$2,100

/ month

$19,250

/ year
  • Includes all Modules
  • Copy of Make Better Decisions book
  • Daily Briefing Email Bulletin
  • Unlimited Searches
  • Unlimited Support
 

Enterprise

For teams

    All Unlimited Plan features, plus:

    • Multiple Users, or Company-Wide Access

Each plan includes the following modules


Pharmaceutical Drugs

  • US & International Patents
  • Active and Expired Patents in 134 Countries, Regulatory Protections and Exclusivities
  • Anticipate Generic Entry
  • Loss-of-Exclusivity Dates, Paragraph IV Challenges, Tentative Approvals, Authorized Generics, and more…
  • Find Commercial Opportunities
  • Single Source Off-Patent Drugs, Search Patents by Dosage Form / Therapeutic Class
  • Drug Sourcing
  • API, Finished Product Suppliers, First Generic Entrants

Biologic Drugs

  • US & International Patents
  • Active and Expired Patents in 134 Countries
  • Track Biosimilar Development
  • Finished Product Suppliers
  • Manufacturers

Excipients

  • Tie inactive ingredients to drug patents
  • Track drug patents based on their excipients
  • Identify clients for excipients
  • Find upcoming generic manufacturers needing your inactive ingredients

Investigational Drugs

  • Drug Candidates in Phase I-III Clinical Trials
  • US & International Patents
  • Active and Expired Patents in 134 Countries
  • Clinical Trial Progress
  • API Vendors

US Drug Patent Litigation

  • US District Court Cases
  • Patent Infringement, Contract Disputes, Antitrust, etc.
  • Patent Trial and Appeal Board
  • PTAB inter partes review, post-grant review

US Drug Prices

  • Brand vs. Generic Drug Price Gap
  • Find generic entry opportunities
  • Average Pharmacy Cost
  • Set reasonable launch prices
  • Best-Available Price
  • See price ranges

US Top Drug Sales

  • Annual Gross Revenues & Units Sold
  • Prescription Payment Methods
  • Self-Paid, Private Insurance, Medicaid, etc.
  • Pharmacy Locations & Types
  • Mail-order, Drugstore, in-Clinic, etc.

DrugPatentWatch cited by CNN, NEJM, Nature Journals, and more …

User Testimonials

❝ Information you don´t find anywhere else ❞

❝ I like best … the flexible subscription plans (by module, by month, by year, etc.) ❞

❝ My overall experience with DPW is very positive. The team is generally supportive and their features are growing over time. ❞

❝ Quick and easy to understand summaries, along with all the necessary links for further analysis. ❞

❝ Knowing when drugs are coming off patent and who to contract with has enabled us to stay ahead fo the curve and align ourselves with the proper vendors. ❞

❝ Drugpatentwatch is an excellent opportunity for LATAM companies to access information on expired and protected patents from the USA and worldwide in a friendly and easy manner. ❞

❝ This is a great service with lots of insightful information. ❞

❝ I like the interface, and how it updates with news ❞

❝ Found the results very comprehensive. The information told me who potential competitors are and what they are planning based on not only their NDAs and patents, but also references to clinical trials. ❞

Clients in 74 Countries